Resmed (RMD) Accumulated Depreciation & Amortization (2010 - 2026)

Resmed (RMD) has 17 years of Accumulated Depreciation & Amortization data on file, last reported at $156.6 million in Q1 2026.

• For the quarter ending Q1 2026, Accumulated Depreciation & Amortization rose 258.48% year-over-year to $156.6 million; the trailing twelve-month figure through Mar 2026 stood at $156.6 million (up 258.48% YoY), and the FY2025 full-year result was $198.5 million, up 12.21% from the prior year.
• Accumulated Depreciation & Amortization for Q1 2026 stood at $156.6 million, up from $49.9 million in the prior quarter.
• Across five years, Accumulated Depreciation & Amortization topped out at $198.5 million in Q2 2025 and bottomed at $36.3 million in Q3 2022.
• The 5-year median for Accumulated Depreciation & Amortization is $74.0 million (2022), against an average of $95.8 million.
• The widest annual swing landed in 2025, when Accumulated Depreciation & Amortization sank 67.21%; it then surged 258.48% in 2026.
• A 5-year view of Accumulated Depreciation & Amortization shows it stood at $74.0 million in 2022, then sank by 39.51% to $44.8 million in 2023, then jumped by 103.57% to $91.2 million in 2024, then slumped by 45.28% to $49.9 million in 2025, then jumped by 213.85% to $156.6 million in 2026.
• The last three Accumulated Depreciation & Amortization figures came in at $156.6 million (Q1 2026), $49.9 million (Q4 2025), and $47.7 million (Q3 2025), per Business Quant data.

Peer Comparison